Does DACLATASVIR Cause Hepatocellular carcinoma? 419 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 419 reports of Hepatocellular carcinoma have been filed in association with DACLATASVIR. This represents 7.5% of all adverse event reports for DACLATASVIR.
419
Reports of Hepatocellular carcinoma with DACLATASVIR
7.5%
of all DACLATASVIR reports
71
Deaths
126
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From DACLATASVIR?
Of the 419 reports, 71 (16.9%) resulted in death, 126 (30.1%) required hospitalization, and 39 (9.3%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLATASVIR. However, 419 reports have been filed with the FAERS database.
What Other Side Effects Does DACLATASVIR Cause?
Fatigue (510)
Headache (411)
Hepatitis c (400)
Drug ineffective (385)
Treatment failure (310)
Nausea (287)
Anaemia (251)
Ascites (205)
Off label use (199)
Insomnia (183)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
SOFOSBUVIR\VELPATASVIR (161)
Which DACLATASVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
DACLATASVIR vs DACLIZUMAB
DACLATASVIR vs DACOMITINIB
DACLATASVIR vs DACTINOMYCIN
DACLATASVIR vs DALBAVANCIN
DACLATASVIR vs DALFAMPRIDINE